Elbit Systems Ltd. (ESLT) Stock Analysis

57.0/100
Hold Not Halal Industrials
Price $706.62
Market Cap $33.13B
52-Week Change +49.84%

Is ESLT a good investment?

Elbit Systems Ltd. (ESLT) has a Plutrex AI rating of 57.0/100 as of November 13, 2026, indicating a Hold consensus. The stock is not classified as halal-compliant. Key strength: Fortress balance sheet: D/E 0.15x (71% below industry average 0.52x), $963M cash, $693M annual FCF — provides existential resilience, self-funding capacity, and M&A optionality unavailable to leveraged peers; FCF yield validates earnings quality. Main concern: Valuation remains deeply elevated: P/E 54.65x is 88.6% above industry average 28.98x; PEG 2.57x is 31.3% above industry average 1.96x; at fair PEG 1.5x the implied P/E is ~32x, suggesting 40%+ overvaluation even after 10.5% price decline; analyst consensus target $820 implies only 13.4% upside — insufficient margin of safety at current price.

Investment Summary

ESLT is a high-quality Israeli defense electronics company trading at $723.00 — down 10.5% from $807.41 fourteen days ago — bringing it meaningfully closer to, but still above, my prior entry zone of $650-$690. The core thesis remains unchanged: exceptional financial fortress (D/E 0.15x, $963M cash, $693M annual FCF) paired with 21.2% 5-year forward EPS CAGR, but packaged inside a valuation that remains difficult to justify on fundamentals alone (P/E 54.65x, PEG 2.57x vs. industry avg 1.96x). The 10.5% price decline has eased — not resolved — the valuation concern: PEG dropped from 2.87x to 2.57x, and analyst target upside expanded from 1.6% to 13.4%. News sentiment is exceptionally strong at 98.2/100, with $260M PULS rocket artillery contract, $170M U.S. manufacturing expansion (Twenty-Six Defense), and autonomous drone/ISTAR contract wins demonstrating sustained demand across multiple defense verticals. The stock is now approaching the upper end of my previously stated entry zone. Hold for existing owners; new entrants should wait for a pullback to $650-$690 for adequate margin of safety.

Key Strengths

Key Concerns

Plutrex 10-Factor AI Breakdown

Financial Health
88/100
Growth Potential
52/100
Valuation
22/100
Profitability
52/100
Debt Management
95/100
Analyst Sentiment
42/100
Technical Momentum
48/100
Insider Confidence
60/100
News Sentiment
92/100

Fundamental Analysis

ESLT's fundamentals present a classic quality-at-a-price dilemma. Financial health is exceptional: D/E ratio 0.15x (vs. industry 0.52x — 71% less leverage), $963M cash on hand, and $693M annual FCF generation that covers all debt obligations many times over. ROE of 15.2% is achieved almost entirely through operational efficiency given the near-zero leverage — a quality signal. Growth is legitimate but moderating: 5-year forward EPS CAGR 21.2% (vs. industry 22.0% — essentially at parity), next-year EPS growth 19.7% (vs. industry avg 28.4% — 30.6% gap), and historical YoY EPS growth 39.8% decelerating to the forward 21.2% projection. Revenue growth 15.9% lags the defense sector materially. Profitability is below-peer: gross margin 25.0% (above industry 20.2% — strength), but operating margin 9.4% (vs. industry 10.9% — 13.8% below peers) and net margin 7.4% (vs. industry 8.7% — 14.9% below peers) indicate that SG&A and R&D absorption erodes the gross profit advantage. Valuation remains the dominant concern: P/E 54.65x vs. industry 28.98x (+88.6% premium), PEG 2.57x vs. industry 1.96x (+31.3% premium). At a fair PEG of 1.5x applied to 21.2% 5-year EPS growth, fair P/E approximates 32x — suggesting the stock is roughly 40-45% above intrinsic value at current price, though the decline from $807 has partially compressed this gap.

News Sentiment

Elbit Systems is on a contract-winning streak that's hard to ignore — but Wall Street is watching to see if the company can grow into its lofty stock price. The Israeli defense electronics giant has racked up hundreds of millions in new deals in recent months, signaling that global demand for advanced military technology is showing no signs of slowing. Most notably, Elbit was awarded a $260 million contract to supply PULS rocket artillery systems — a next-generation precision strike weapon that multiple NATO-aligned nations have been rushing to procure. That came alongside a separate $170 million deal to establish and operate a new U.S.-based manufacturing facility, part of the company's Twenty-Six Defense subsidiary — a strategic move that could unlock billions in future American defense contracts that were previously off-limits to foreign-headquartered suppliers. The company is also winning business in airborne ISTAR (Intelligence, Surveillance, Target Acquisition and Reconnaissance) solutions, the high-tech surveillance systems that militaries now consider essential. Meanwhile, analysts are asking whether Elbit has what it takes to meet growing earnings expectations — a question that matters enormously given the stock's premium valuation. The company's new autonomous drone unit, Fuse AI, positions it squarely in the fastest-growing corner of modern warfare. For everyday investors, the story is straightforward: Elbit is winning the contracts, but the stock price already reflects a lot of optimism. The question is whether these deals can keep growing fast enough to justify the premium.

Risk Assessment

PRIMARY RISK: Valuation compression. At P/E 54.65x and PEG 2.57x, any earnings miss, guidance reduction, or growth deceleration below 21.2% 5-year CAGR would trigger significant multiple de-rating. A compression to industry average P/E of 28.98x would imply a stock price near $383 — a 47% drawdown. SECONDARY RISK: Near-term growth disappointment. 1-year forward EPS growth 19.7% already lags the industry average 28.4% — if contract execution slips or defense budgets tighten, the premium valuation evaporates quickly. TERTIARY RISK: Geopolitical/regulatory. ESLT is an Israeli defense company; U.S. arms export restrictions, escalating Middle East conflict disruptions to supply chain, or Israeli government budget cuts could all impair near-term revenue. MITIGATION: (1) Only enter at $650-$695 zone where PEG approaches 2.3x and risk/reward improves to 2.2x; (2) Stop at $605 limits downside to ~10%; (3) Fortress balance sheet (D/E 0.15x, $963M cash) provides fundamental backstop and rules out financial distress even in a prolonged downcycle; (4) 5-year EPS CAGR 21.2% at industry parity provides long-term anchor if held through short-term volatility.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is ESLT a halal stock?

No, Elbit Systems Ltd. (ESLT) is currently not classified as halal by AAOIFI criteria.

What is Plutrex's AI rating for ESLT?

Elbit Systems Ltd. (ESLT) has a Plutrex AI rating of 57.0/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is ESLT a good investment?

According to Plutrex AI, ESLT has a Hold rating (57.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in ESLT?

US stocks like ESLT can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in ESLT?

Plutrex AI identifies the main risks for ESLT by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with ElBarake AI about ESLT

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open ESLT in ElBarake